Lisata Therapeutics Inc | WebDisclosure

Basculer en Français

9477	Companies
185475	Keywords
117817	Articles
99317	Press releases

Headlines Articles Press releases Lisata Therapeutics Inc

Home
Companies
Lisata Therapeutics Inc

BRIEF

published on 11/17/2025 at 15:24, 17 days 23 hours ago

First Berlin Equity Research Reaffirms BUY Rating for Lisata Therapeutics

BUY Rating Research Update Strategic Collaborations Lisata Therapeutics Certepetide Platform
BRIEF

published on 11/17/2025 at 15:24, 17 days 23 hours ago

First Berlin Equity Research réaffirme sa recommandation d'achat sur Lisata Therapeutics

Mise À Jour De La Recherche Collaborations Stratégiques Évaluation D'achat Lisata Thérapeutique Plateforme Certepetide
PRESS RELEASE

published on 11/17/2025 at 15:19, 17 days 23 hours ago

Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates Lisata Therapeutics Inc (ISIN: US1280583022) with a BUY rating and USD 15.00 price target. Results show operational improvement and positive data on certepetide platform

First Berlin Equity Research BUY Rating Research Update Lisata Therapeutics Inc Certepetide Platform
BRIEF

published on 08/18/2025 at 13:46, 3 months 18 days ago

Lisata Therapeutics Inc Gains Positive Outlook in Recent Research Update

Clinical Trials Research Update Pancreatic Cancer Lisata Therapeutics Certepetide
BRIEF

published on 08/18/2025 at 13:46, 3 months 18 days ago

Lisata Therapeutics Inc. obtient des perspectives positives dans une récente mise à jour de recherche

Essais Cliniques Cancer Du Pancréas Mise À Jour De La Recherche Lisata Therapeutics Certepetide
PRESS RELEASE

published on 08/18/2025 at 13:41, 3 months 18 days ago

Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for Lisata Therapeutics Inc post H1/25 financial results, noting positive outcomes on pancreatic cancer indications

First Berlin Equity Research Buy Recommendation Research Update Pancreatic Cancer Lisata Therapeutics Inc
BRIEF

published on 04/01/2025 at 15:36, 8 months 3 days ago

Lisata Therapeutics Inc Announces Positive FY/24 Results

Lisata Therapeutics Certepetide FY/24 Results Cancer Studies GATC Health Collaboration
BRIEF

published on 04/01/2025 at 15:36, 8 months 3 days ago

Lisata Therapeutics Inc. annonce des résultats positifs pour l'exercice 2024

Résultats De L'exercice 2024 Lisata Therapeutics Certepetide Études Sur Le Cancer Collaboration En Matière De Santé Du GATC
PRESS RELEASE

published on 04/01/2025 at 15:31, 8 months 3 days ago

Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Lisata Therapeutics Inc (ISIN: US1280583022) research with a Buy recommendation and USD 15.00 target price. Lisata's FY/24 results exceeded expectations, with promising developments in certepetide trials and AI collaboration

First Berlin Equity Research Buy Recommendation Research Update Certepetide Lisata Therapeutics Inc
BRIEF

published on 01/29/2025 at 09:56, 10 months 7 days ago

Lisata Therapeutics: Promising Preliminary Results and Buy Recommendation

Buy Recommendation Lisata Therapeutics Certepetide ASCEND Trial PDAC Treatment

Accesswire

Published on 12/05/2025 at 14:00, 32 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 32 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 11 hours 57 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours 2 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 32 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 9 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 15 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 22 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 47 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 32 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 13:58, 33 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 5 hours 47 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 5 hours 47 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 5 hours 50 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 20 hours 17 minutes ago

Résiliation d'une convention conclue entre actionnaires

View all LES ECHOS COMFI WIRE